HPV status-independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18, EBF3, IRX1, and SEPT9, but not SLC5A8, in head and neck squamous cell carcinomas

Genes Chromosomes and Cancer

Volumn 49, Issue 4, 2010, Pages 319-326

  Bennett, Kristi L ^a   Lee, Walter ^a,d   Lamarre, Eric ^a   Zhang, Xiatong ^a   Seth, Rahul ^a   Scharpf, Joseph ^a   Hunt, Jennifer ^a,e   Eng, Charis ^a,b,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RADIATION EXPOSURE; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; WART VIRUS;

ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; CATION TRANSPORT PROTEINS; CYTOSKELETAL PROTEINS; DATA INTERPRETATION, STATISTICAL; DNA METHYLATION; GENES, TUMOR SUPPRESSOR; GTP-BINDING PROTEINS; HEAD AND NECK NEOPLASMS; HOMEODOMAIN PROTEINS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NERVE TISSUE PROTEINS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; RADIOTHERAPY; SMOKING; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

HUMAN PAPILLOMAVIRUS; NICOTIANA TABACUM;

EID: 77949377722     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20742     Document Type: Article

References (23)

1. Amir S, Wang R, Matzkin H, Simons JW, Mabjeesh NJ. 2006. MSF-A interacts with hypoxia-inducible factor-1alpha and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis. Cancer Res 66:856-866.
2. Arndt S, Poser I, Schubert T, Moser M, Bosserhoff AK. 2005. Cloning and functional characterization of a new Ski homolog, Fussel-18, specifically expressed in neuronal tissues. Lab Invest 85:1330-1341.
3. Bennett KL, Karpenko M, Lin MT, Claus R, Arab K, Dyckhoff G, Plinkert P, Herpel E, Smiraglia D, Plass C. 2008. Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma. Cancer Res 68:4494-4499.
4. Chen AA, Marsit CJ, Christensen BC, Houseman EA, McClean MD, Smith JF, Bryan JT, Posner MR, Nelson HH, Kelsey KT. 2009. Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer. Carcinogenesis 30:977-981.
5. Chuang AY, Chuang TC, Chang S, Zhou S, Begum S, Westra WH, Ha PK, Koch WM, Califano JA. 2008. Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma. Oral Oncol 44:915-919.
6. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. 2007. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356: 1944-1956.
7. Ferguson CA, Tucker AS, Heikinheimo K, Nomura M, Oh P, Li E, Sharpe PT. 2001. The role of effectors of the activin signalling pathway, activin receptors IIA and IIB, and Smad2, in patterning of tooth development. Development 128: 4605-4613.
8. Gollin SM. 2005. Mechanisms leading to chromosomal instability. Semin Cancer Biol 15:33-42.
9. Haddad RI, Shin DM. 2008. Recent advances in head and neck cancer. N Engl J Med 359:1143-1154.
10. Henken FE, Wilting SM, Overmeer RM, van Rietschoten JG, Nygren AO, Errami A, Schouten JP, Meijer CJ, Snijders PJ, Steenbergen RD. 2007. Sequential gene promoter methylation during HPV-induced cervical carcinogenesis. Br J Cancer 97: 1457-1464.
11. Jones PL, Wolffe AP. 1999. Relationships between chromatin organization and DNA methylation in determining gene expression. Semin Cancer Biol 9:339-347.
12. Katargin AN, Pavlova LS, Kisseljov FL, Kisseljova NP. 2009. Hypermethylation of genomic 3.3-kb repeats is frequent event in HPV-positive cervical cancer. BMC Med Genomics 2:30.
13. Lu D, Hoory T, Monie A, Wu A, Wang MC, Hung CF. 2009. Treatment with demethylating agent, 5-aza-2́-deoxycytidine enhances therapeutic HPV DNA vaccine potency. Vaccine 27:4363-4369.
14. Overmeer RM, Henken FE, Bierkens M, Wilting SM, Timmerman I, Meijer CJ, Snijders PJ, Steenbergen RD. 2009. Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis. J Pathol 219:327-336.
15. Ragin CC, Taioli E, Weissfeld JL, White JS, Rossie KM, Modugno F, Gollin SM. 2006. 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br J Cancer 95:1432-1438.
16. Richards KL, Zhang B, Baggerly KA, Colella S, Lang JC, Schuller DE, Krahe R. 2009. Genome-wide hypomethylation in head and neck cancer is more pronounced in HPV-negative tumors and is associated with genomic instability. PLoS One 4:e4941.
17. Singh H, Sekinger EA, Gross DS. 2000. Chromatin and cancer: Causes and consequences. J Cell Biochem Suppl Suppl 35:61-68.
18. Springer J, Scholz FR, Peiser C, Groneberg DA, Fischer A. 2004. SMAD-signaling in chronic obstructive pulmonary disease: Transcriptional down-regulation of inhibitory SMAD 6 and 7 by cigarette smoke. Biol Chem 385:649-653.
19. Taioli E, Ragin C, Wang XH, Chen J, Langevin SM, Brown AR, Gollin SM, Garte S, Sobol RW. 2009. Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation. BMC Cancer 9:354.
20. Thangaraju M, Gopal E, Martin PM, Ananth S, Smith SB, Prasad PD, Sterneck E, Ganapathy V. 2006. SLC5A8 triggers tumor cell apoptosis through pyruvate-dependent inhibition of histone deacetylases. Cancer Res 66:11560-11564.
21. Vu HL, Sikora AG, Fu S, Kao J. 2009. HPV-induced oropharyngeal cancer, immune response and response to therapy. Cancer Lett (in press).
22. Warnakulasuriya S. 2009. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45:309-316.
23. Zhao LY, Niu Y, Santiago A, Liu J, Albert SH, Robertson KD, Liao D. 2006. An EBF3-mediated transcriptional program that induces cell cycle arrest and apoptosis. Cancer Res 66:9445-9452.